Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Conmed
(NYSE:CNMD)
Intraday
$65.78
3.88
[6.27%]
After-Hours
$65.78
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$65.78
3.88
[6.27%]
At close: Apr 26
$65.78
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings were released on Wed Apr 24th, after the market close
The most recent conference call was at 16:30 PM, 3 days ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Conmed Stock (NYSE:CNMD)
Conmed Stock (NYSE: CNMD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 25, 2024
JP Morgan Maintains Overweight on Conmed, Lowers Price Target to $75
Benzinga Newsdesk
-
2 days ago
CONMED shares are trading lower after the company reported Q1 financial results. Needham, Piper Sandler and Wells Fargo lowered their respective price targets on the stock.
Benzinga Newsdesk
-
2 days ago
Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $77
Benzinga Newsdesk
-
2 days ago
Piper Sandler Maintains Overweight on Conmed, Lowers Price Target to $95
Benzinga Newsdesk
-
2 days ago
Analyst Scoreboard: 5 Ratings For Conmed
Benzinga Insights
-
2 days ago
Needham Maintains Buy on Conmed, Lowers Price Target to $107
Benzinga Newsdesk
-
2 days ago
Wednesday, April 24, 2024
CONMED Corporation Promotes Patrick Beyer To Chief Operating Officer, Effective Immediately
Benzinga Newsdesk
-
3 days ago
CONMED Sees FY24 Adj. EPS $4.25-$4.35 Vs $4.33 Est.; Revenue $1.330B-$1.355B Vs $1.350B Est.
Benzinga Newsdesk
-
3 days ago
Conmed Q1 2024 Adj EPS $0.79 Beats $0.74 Estimate, Sales $312.273M Beat $306.776M Estimate
Benzinga Newsdesk
-
3 days ago
Thursday, February 01, 2024
Cracking The Code: Understanding Analyst Reviews For Conmed
Benzinga Insights
-
Feb 1, 2024, 4:00PM
Piper Sandler Maintains Overweight on Conmed, Lowers Price Target to $100-Report Released on 31 January 2024
Benzinga Newsdesk
-
Feb 1, 2024, 3:18PM
CONMED shares are trading lower after the company reported worse-than-expected Q4 financial results.
Benzinga Newsdesk
-
Feb 1, 2024, 10:20AM
JP Morgan Maintains Overweight on Conmed, Lowers Price Target to $115
Benzinga Newsdesk
-
Feb 1, 2024, 9:40AM
These Analysts Revise Their Forecasts On CONMED After Q4 Results
Avi Kapoor
-
Feb 1, 2024, 8:42AM
Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $98
Benzinga Newsdesk
-
Feb 1, 2024, 8:27AM
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
-
Feb 1, 2024, 7:48AM
Needham Maintains Buy on Conmed, Raises Price Target to $129
Benzinga Newsdesk
-
Feb 1, 2024, 7:22AM
Wednesday, January 31, 2024
Recap: Conmed Q4 Earnings
Benzinga Insights
-
Jan 31, 2024, 4:15PM
Conmed Q4 Adj EPS $1.06 Misses $1.11 Estimate, Sales $327.05M Miss $332.20M Estimate
Benzinga Newsdesk
-
Jan 31, 2024, 4:13PM
Earnings Scheduled For January 31, 2024
Benzinga Insights
-
Jan 31, 2024, 6:09AM
Tuesday, January 30, 2024
Conmed's Earnings: A Preview
Benzinga Insights
-
Jan 30, 2024, 1:01PM
Thursday, October 26, 2023
Stifel Maintains Buy on Conmed, Lowers Price Target to $120
Benzinga Newsdesk
-
Oct 26, 2023, 3:27PM
Piper Sandler Maintains Overweight on Conmed, Lowers Price Target to $130
Benzinga Newsdesk
-
Oct 26, 2023, 2:54PM
Wells Fargo Maintains Equal-Weight on Conmed, Lowers Price Target to $107
Benzinga Newsdesk
-
Oct 26, 2023, 8:56AM
Needham Maintains Buy on Conmed, Lowers Price Target to $119
Benzinga Newsdesk
-
Oct 26, 2023, 5:33AM
Wednesday, October 25, 2023
Conmed Q3 EPS $0.90 Beats $0.83 Estimate, Sales $304.58M Beat $300.91M Estimate
Benzinga Newsdesk
-
Oct 25, 2023, 4:24PM
Earnings Scheduled For October 25, 2023
Benzinga Insights
-
Oct 25, 2023, 7:32AM
Tuesday, October 24, 2023
Conmed's Earnings: A Preview
Benzinga Insights
-
Oct 24, 2023, 2:01PM
Thursday, July 27, 2023
JP Morgan Maintains Overweight on Conmed, Raises Price Target to $145
Benzinga Newsdesk
-
Jul 27, 2023, 9:55AM
Needham Maintains Buy on Conmed, Raises Price Target to $140
Benzinga Newsdesk
-
Jul 27, 2023, 5:41AM
Keybanc Maintains Overweight on Conmed, Raises Price Target to $141
Benzinga Newsdesk
-
Jul 27, 2023, 4:34AM
Wednesday, July 26, 2023
CONMED Raises FY23 Adj EPS Outlook From $3.30-$3.50 To $3.40-$3.55, Consensus $3.42
Benzinga Newsdesk
-
Jul 26, 2023, 5:41PM
CONMED Raises FY23 Revenue Outlook From $1.205B-$1.250B To $1.23B-$1.26B, Consensus $1.23B
Benzinga Newsdesk
-
Jul 26, 2023, 5:40PM
Conmed Q2 Adj EPS $0.83 Beats $0.79 Estimate, Sales $317.65M Beat $306.09M Estimate
Benzinga Newsdesk
-
Jul 26, 2023, 4:10PM
Earnings Scheduled For July 26, 2023
Benzinga Insights
-
Jul 26, 2023, 4:18AM
Monday, July 24, 2023
Analyst Ratings for Conmed
Benzinga Insights
-
Jul 24, 2023, 5:00PM
Needham Reiterates Buy on Conmed, Maintains $139 Price Target
Benzinga Newsdesk
-
Jul 24, 2023, 7:02AM
Monday, June 05, 2023
Needham Maintains Buy on Conmed, Raises Price Target to $139
Benzinga Newsdesk
-
Jun 5, 2023, 6:22AM
Monday, May 22, 2023
Where Conmed Stands With Analysts
Benzinga Insights
-
May 22, 2023, 12:02PM
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Benzinga Insights
-
May 22, 2023, 11:00AM
CL King Initiates Coverage On Conmed with Buy Rating, Announces Price Target of $140
Benzinga Newsdesk
-
May 22, 2023, 8:16AM
Tuesday, May 09, 2023
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
-
May 9, 2023, 1:35PM
Wednesday, May 03, 2023
Conmed Recent Insider Activity
Benzinga Insights
-
May 3, 2023, 11:06AM
Thursday, April 27, 2023
Analyst Impressed With CONMED's Upbeat Q1 Performance and Raised Guidance, Bullish On Organic Growth
Vandana Singh
-
Apr 27, 2023, 3:18PM
CONMED shares are trading higher after the company reported better-than-expected Q1 results and issued strong guidance.
Benzinga Newsdesk
-
Apr 27, 2023, 12:51PM
The Latest Analyst Ratings for Conmed
Benzinga Insights
-
Apr 27, 2023, 12:00PM
Stifel Maintains Buy on Conmed, Raises Price Target to $130
Benzinga Newsdesk
-
Apr 27, 2023, 11:54AM
CORRECTION: CONMED Guidance Was Tagged Under The Wrong Stock, CONMED Ticker Is "CNMD"
Happy Mohamed
-
Apr 27, 2023, 10:24AM
Piper Sandler Maintains Overweight on Conmed, Raises Price Target to $128
Benzinga Newsdesk
-
Apr 27, 2023, 10:15AM
Wells Fargo Maintains Equal-Weight on Conmed, Raises Price Target to $119
Benzinga Newsdesk
-
Apr 27, 2023, 8:10AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch